Last Posted: Nov 08, 2019
- Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
D Chowell et al, Nature Medicine, November 7, 2019 - A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab.
Friedlander Philip et al. Journal for immunotherapy of cancer 2018 6(1) 90 - NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
Ettinger David S et al. Journal of the National Comprehensive Cancer Network : JNCCN 2018 16(7) 807-821 - Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death.
Kulkarni Prathamesh M et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Oct - Harnessing the Power of Microbes to Fight Cancer
JP Zegerac, Medscape, October 25, 2019 - Vision of the Future of Medical Science
Francis Collins, Time, October 25, 2019 - Angelina Jolie: Medical Advances in Women's Health Are Important. But They're Only Part of the Picture
A Jolie, Time, October 24, 2019 - CRISPR-Cas9 as a Tool in Cancer Therapy.
Zatloukalová P et al. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 32(Supplementum 3) 13-18 - Understanding Precision Medicine And AI Within The Life Cycle Of Technology Revolutions
D Shaywitz, Forbes, October 16, 2019 - Towards precision oncology in advanced prostate cancer.
Ku Sheng-Yu et al. Nature reviews. Urology 2019 Oct
No hay comentarios:
Publicar un comentario